ArriVent BioPharma, Inc. AVBP Return on assets
Return on assets at other companies
Other financials
Where this comes from
Calculated from ArriVent BioPharma, Inc.’s reported figures.
Based on trailing twelve months.
The official record: ArriVent BioPharma, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about ArriVent BioPharma, Inc.'s return on assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ArriVent BioPharma, Inc.'s return on assets?
- ArriVent BioPharma, Inc. (AVBP) reported return on assets of -51.4% in Q1 2026.
- How has ArriVent BioPharma, Inc.'s return on assets changed year-over-year?
- ArriVent BioPharma, Inc.'s return on assets decreased by 9.6% year-over-year, from -46.9% to -51.4%.
- What does return on assets mean?
- Trailing-twelve-month net income divided by average total assets. Measures how efficiently the asset base generates profit, independent of how those assets are financed. Computed as net income over average total assets — note this is OpenCapital's standard definition and may differ from data vendors that use alternative numerators.